BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6244998)

  • 1. Enzyme-linked immunosorbent assay for detection of poliovirus antigen and antibody.
    Moynihan M; Ladefoged P; Mathiesen L
    Dev Biol Stand; 1980; 46():203-6. PubMed ID: 6244998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct enzyme linked immunosorbent assay (ELISA) for quantification of poliomyelitis virus D-antigen.
    Souvras M; Montagnon B; Fanget B; van Wezel AL; Hazendonk AG
    Dev Biol Stand; 1980; 46():197-202. PubMed ID: 6244997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratypic differentiation of poliovirus strains by enzyme-linked immunosorbent assay (ELISA): poliovirus type 1.
    Glikmann G; Moynihan M; Petersen I; Vestergaard BF
    Dev Biol Stand; 1983; 55():199-208. PubMed ID: 6203794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic potency of inactivated poliovirus vaccines.
    Moynihan M; Petersen I
    Dev Biol Stand; 1981; 47():129-33. PubMed ID: 6262143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.
    Singer C; Knauert F; Bushar G; Klutch M; Lundquist R; Quinnan GV
    J Biol Stand; 1989 Apr; 17(2):137-50. PubMed ID: 2541133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of ELISA for screening McAb against type III polioviruses and its antigenic analysis].
    Gu FZ; Wang SH; Sun YY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Oct; 7(5):359-63. PubMed ID: 2421926
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).
    Rezapkin G; Dragunsky E; Chumakov K
    Biologicals; 2005 Mar; 33(1):17-27. PubMed ID: 15713553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.
    Rezapkin G; Martin J; Chumakov K
    Biologicals; 2005 Mar; 33(1):29-39. PubMed ID: 15713554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of poliovirus antigen measurements in vitro and in small animals.
    von Seefried A; Bryce E; Campbell JB; Chun JH; Laurence GD; Scollard N; Tsai KS
    Dev Biol Stand; 1981; 47():91-100. PubMed ID: 6262165
    [No Abstract]   [Full Text] [Related]  

  • 11. D-antigen determination in polio vaccine production: comparison of gel diffusion and ELISA methods.
    van der Marel P; Hazendonk AG; van Wezel AL
    Dev Biol Stand; 1981; 47():101-8. PubMed ID: 6262140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency test of killed polio vaccines. Statistical analysis of test on chicken and preliminary results in combination with ELISA D-antigen determinations.
    Larbaigt G; Moulin J; Souvras M; Gibelin N; Beranger G
    Dev Biol Stand; 1981; 47():113-8. PubMed ID: 6262141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
    Shyrobokov VP; Nikolaienko IV; Kopanytsia LV; Solohub VK; Ivanova OIe
    Mikrobiol Z; 1997; 59(6):27-36. PubMed ID: 9511373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double antibody sandwich ELISA for the detection of rubella virus antigen.
    Komatsu H; Suzuki Y; Matumoto M
    Kitasato Arch Exp Med; 1992 Apr; 65(1):23-31. PubMed ID: 1336082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sera collected before introduction of contaminated polio vaccine contain antibodies against SV40.
    Geissler E; Konzer P; Scherneck S; Zimmermann W
    Acta Virol; 1985 Sep; 29(5):420-3. PubMed ID: 2866697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antigenicity determination of inactivated poliovirus--the micro-neutralization inhibition test].
    Jiang SD; Pye D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Aug; 7(4):309-12. PubMed ID: 3011295
    [No Abstract]   [Full Text] [Related]  

  • 17. Avidity and titers of the antibody response to two inactivated poliovirus vaccines with different antigen content.
    Mellander L; Böttiger M; Hanson LA; Taranger J; Carlsson B
    Acta Paediatr; 1993; 82(6-7):552-6. PubMed ID: 8393360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An ELISA system based on the specific class Y (IgY) antibodies from egg yolks for the quantitative determination of D-antigen in inactivated poliovirus vaccines].
    Ivanov AP; Kozlov VG; Klebleeva TD; Ivanova OE; Kiktenko AV
    Vopr Virusol; 2014; 59(6):39-42. PubMed ID: 25929036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid-phase blocking sandwich enzyme-linked immunosorbent assay for detection of antibodies against foot-and-mouth disease virus in water buffalo sera.
    Araújo JP; Montassier HJ; Pinto AA
    Am J Vet Res; 1996 Jun; 57(6):840-3. PubMed ID: 8725810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an enzyme-linked immunosorbent assay based on binding inhibition for type-specific quantification of poliovirus neutralization-relevant antibodies.
    Hashido M; Horie H; Abe S; Doi Y; Hashizume S; Agboatwalla M; Isomura S; Nishio O; Hagiwara A; Inouye S
    Microbiol Immunol; 1999; 43(1):73-7. PubMed ID: 10100750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.